IL37 and autism: The significant potency of IL-38, together with the broad anti-inflammatory properties of IL-37 and its natural presence in the human body, indicates that therapies utilizing these cytokines may offer effective and safe therapeutic alternatives for individuals with autism (47, 135, 136).